- AI
- Molecular Imaging
- CT
- X-Ray
- Ultrasound
- MRI
- Facility Management
- Mammography
New LCD monitors broaden palettes of color and gray-scale tones
Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
Eizo Nanao Technologies is showing a pair of new multipurpose 3-megapixel liquid crystal display monitors at the RSNA meeting. The monitors, released earlier this fall, are now available for sale worldwide.
The monochrome RadiForce G33 is designed for PACS, chest radiography, CT, MRI, and angiography. It produces a palette of 8161 gray-scale tones - 4096, or 12 bits, of them can be displayed simultaneously.
The unit incorporates Eizo's aperture modulation technology, which intensifies the differences between black and white tones by enabling a different area ratio for each subpixel. The G33 has a built-in sensor that allows precise remote calibration. Its Digital Uniformity Equalizer unifies the luminance of the backlight.
The color and monochrome RadiForce R31 for CT, MRI, PET, and 3D rendering has a 10-bit color input compatibility that can display up to a trillion colors simultaneously. The R31's image rotation technology permits users to switch easily from landscape to portrait mode. It also eliminates the need for special software for gray-scale rendering without banding or color seepage.
Can Generative AI Facilitate Simulated Contrast Enhancement for Prostate MRI?
January 14th 2025Deep learning synthesis of contrast-enhanced MRI from non-contrast prostate MRI sequences provided an average multiscale structural similarity index of 70 percent with actual contrast-enhanced prostate MRI in external validation testing from newly published research.
Can MRI Have an Impact with Fertility-Sparing Treatments for Endometrial and Cervical Cancers?
January 9th 2025In a literature review that includes insights from recently issued guidelines from multiple European medical societies, researchers discuss the role of magnetic resonance imaging (MRI) in facilitating appropriate patient selection for fertility-sparing treatments to address early-stage endometrial and cervical cancer.
